Showing 1 - 20 results of 993 for search '"Lord, Christopher"' Narrow Search
2
Academic Journal

Authors: Ryan, Colm J.Aff1, IDs4158802301557x_cor1, Devakumar, Lovely Paul SolomonAff2, IDs4158802301557x_cor2, Pettitt, Stephen J.Aff2, IDs4158802301557x_cor3, Lord, Christopher J.Aff2, IDs4158802301557x_cor4

Superior Title: Nature Genetics. 55(12):2039-2048

8
Book

Contributors: Lord, Christopher, Bursens, Peter, De Bièvre, Dirk, Trondal, Jarle, Wessel, Ramses A.

Superior Title: Lord , C , Bursens , P , De Bièvre , D , Trondal , J & Wessel , R A 2022 , Concluding Reflections : (Re)Legitimation by Institutional Design? in C Lord , P Bursens , D De Bièvre , J Trondal & R A Wessel (eds) , The Politics of Legitimation in the European Union . Routledge/UACES Contemporary European Studies , Routledge , 9781032101408 , pp. 296-303 . https://doi.org/10.4324/9781003217756-20

File Description: application/pdf

9
Book

Contributors: Lord, Christopher, Bursens, Peter, De Bièvre, Dirk, Trondal, Jarle, Wessel, Ramses A.

Superior Title: Lord , C , Bursens , P , De Bièvre , D , Trondal , J & Wessel , R A 2022 , Introduction . in C Lord , P Bursens , D De Bièvre , J Trondal & R A Wessel (eds) , The Politics of Legitimation in the European Union . Routledge/UACES Contemporary European Studies , Routledge , pp. 3-16 . https://doi.org/10.4324/9781003217756-2

File Description: application/pdf

11
Academic Journal

Contributors: Cancer Research UK, AstraZeneca, Breast Cancer Now, Merck KGaA, Cancer Research UK London Research Institute

Superior Title: Hematology/Oncology Clinics of North America ; volume 37, issue 1, page 203-224 ; ISSN 0889-8588

Subject Terms: Oncology, Hematology

15
Academic Journal

File Description: 12 Seiten

16
Academic Journal

Contributors: Catholic University of Leuven = Katholieke Universiteit Leuven (KU Leuven), School for Oncology and Developmental Biology Maastricht (GROW), Maastricht University Maastricht -Maastricht University Medical Centre (MUMC), Maastricht University Maastricht, The institute of cancer research London, University Medical Center Utrecht, Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Institut Curie Paris, Universitair Ziekenhuis Leuven (UZ Leuven), Netherlands Cancer Institute (NKI), Antoni van Leeuwenhoek Hospital, Medical University of Gdańsk, King‘s College London, European Cooperation in Science and Technology, COST: CA19138, Fonds Wetenschappelijk Onderzoek, FWO, KU Leuven, KVB and MDS are funded by the KU Leuven Fund Nadine de Beauffort. TG is funded by FWO through a research fellowship. All authors are part of the European Lobular Breast Cancer Consortium (ELBCC) and the Lobsterpot COST Action (CA19138). The authors thank Anirudh Pabba for the technical assistance with the figures., KVB and MDS are funded by the KU Leuven Fund Nadine de Beauffort. TG is funded by FWO through a research fellowship. All authors are part of the European Lobular Breast Cancer Consortium (ELBCC) and the Lobsterpot COST Action (CA19138). The authors thank Anirudh Pabba for the technical assistance with the figures. None declared. The authors have declared no conflicts of interest.

Superior Title: ISSN: 0923-7534.

Relation: info:eu-repo/semantics/altIdentifier/pmid/35605746; hal-03775796; https://hal.science/hal-03775796; https://hal.science/hal-03775796/document; https://hal.science/hal-03775796/file/1-s2.0-S092375342201167X-main.pdf; PUBMED: 35605746